Securities Times e Company News, Yingke Medical (300677) announced on the evening of February 17 that the company intends to invest in Guoyue Junan No. 8 (Taizhou) equity investment partnership (limited partnership) (referred to as "fund"). The target contribution of the fund is 105 million yuan, of which the company will subscribe 10 million yuan as a limited partner (LP). The fund specially invests in the equity of Feiya Chemical. Feiya Chemical is a world-renowned manufacturer of antioxidants and their intermediates.
英科医疗:拟1000万元参投基金 专项投资飞亚化学
Yingke Medical: plan to invest 10 million yuan in Feiya Chemistry as a special investment fund.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.